33 Results for "

SK-Mel-28

" in MedChemExpress (MCE) Product Catalog:
Products (33)

33 Results for "SK-Mel-28" in MCE Product Catalog:

99
99 Publications Verification
Cat. No.: HY-B0150
CAS No.: 98-92-0
Synonyms: Niacinamide; Nicotinic acid amide
Nicotinamide is a form of vitamin B3 or niacin. Nicotinamide Hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide also inhibits SIRT1. Nicotinamide increases cellular NAD+, ATP, ROS levels. Nicotinamide inhibits tumor growth and improves survival. Nicotinamide also has anti-HBV activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1180
CAS No.: 4880-88-0
Synonyms: (-)-Eburnamonine; (-)-Vincamone
Vinburnine ((-)-Eburnamonine; (-)-Vincamone) is an orally active, blood-brain barrier permeable immunomodulator and apoptosis inducer. Vinburnine drives the secretion of IL-24 by activating the P38/MAPK/ATF3 signaling axis. Vinburnine induces reactive oxygen species production and DNA damage in cancer cells, thereby inhibiting cancer cell proliferation, activating the apoptotic cascade, and enhancing CD8+ T cell function to remodel the tumor immune microenvironment. Vinburnine can be used in the research of diseases such as melanoma .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14454
CAS No.: 21306-65-0
Purity:  99.81%
Synonyms: Triphenyl Compound A
Research Areas:  

Cancer

TPh A (Triphenyl Compound A) is a potent inhibitor of the nuclear protein pirin and binds specifically to pirin with a Ki of 0.6 uM. TPh A disrupts the formation of the bcl3–pirin complex. TPh A can be used as a novel small molecule tool to regulate pirin in cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-147855
CAS No.: 948044-25-5
Purity:  99.76%
Research Areas:  

Cancer

ACA-28 is a potent ERK MAPK signaling modulator. ACA-28 selectively inhibits cancer cell growth and induces apoptosis. ACA-28 can activate nuclear factor erythroid 2-related factor 2 (Nrf2) signaling via inducing ROS production. ACA-28 can be used for the research of cancer, such as melanoma .
loading...
    loading...
Cat. No.: HY-124113
CAS No.: 1224713-90-9
Purity:  99.94%
Synonyms: 4′‐BR
4'-Bromo-resveratrol (4′‐BR) is a dual SIRT1/SIRT3 inhibitor with an IC50 of 0.2 mM for both targets. 4'-Bromo-resveratrol induces caspase-dependent apoptosis, induces G0/G1 cell cycle arrest, and inhiibits proliferation. 4'-Bromo-resveratrol reduces lactate production, glucose uptake, and NAD +/NADH ratio, and downregulates lactate dehydrogenase A and glucose transporter 1 (GLUT1). 4'-Bromo-resveratrol can be used for the research of melanoma .
loading...
    loading...
Cat. No.: HY-130602
CAS No.: 2672512-44-4
Purity:  99.72%
Target:  

PROTACs MEK ERK

Research Areas:  

Cancer

MS432 is a potent and selective MEK1/MEK2 PRORAC degrader. MS432 specifically degrades MEK1 and MEK2 by recruiting the VHL E3 ligase, thereby potently inhibiting the phosphorylation activation of the downstream ERK pathway. MS432 can be used in research related to colorectal cancer and melanoma .
loading...
    loading...
Cat. No.: HY-148059
CAS No.: 1425485-87-5
Purity:  99.15%
Synonyms: B-Raf IN 10
Target:  

Raf

Research Areas:  

Cancer

Uplarafenib (B-Raf IN 10) (Compound C09) is a BRAF inhibitor with an IC50 between 50 and 100 nM. Uplarafenib shows antitumor activity .
loading...
    loading...
Cat. No.: HY-170982
CAS No.: 2756323-28-9
Target:  

PROTACs MEK

Research Areas:  

Cancer

MS910 is a CRBN-recruiting MEK1/2 PROTAC degrader, with a DC50 of 94 nM against MEK1 and 38 nM against MEK2 in SK-MEL-28 cells. MS910 induces the degradation of GSPT1, IKZF1/3 and ZFP91, thereby inhibiting the downstream ERK signaling pathway and cancer cell growth. MS910 is applicable to research related to colorectal cancer and melanoma .
loading...
    loading...
Cat. No.: HY-N4006
CAS No.: 129280-34-8
Isoangustone A is an anticancer and anti-inflammatory agent. Isoangustone A induces cancer cells apoptosis and autophagic cell death .
loading...
    loading...
Cat. No.: HY-150534
CAS No.: 2418579-17-4
Purity:  99.56%
Target:  

Apoptosis

Research Areas:  

Cancer

Anti-melanoma agent 1 (Compound 5m) is an anti-melanoma agent and induces cell apoptosis .
loading...
    loading...
Cat. No.: HY-B0150A
CAS No.: 25334-23-0
Synonyms: Niacinamide hydrochloride; Nicotinic acid amide hydrochloride
Nicotinamide hydrochloride is a form of vitamin B3 or niacin. Nicotinamide hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide hydrochloride also inhibits SIRT1. Nicotinamide hydrochloride increases cellular NAD+, ATP, ROS levels. Nicotinamide hydrochloride inhibits tumor growth and improves survival. Nicotinamide hydrochloride also has anti-HBV activity .
loading...
    loading...
Cat. No.: HY-175435
CAS No.: 3094183-98-6
Target:  

PROTACs Raf ERK

Research Areas:  

Neurological Disease Cancer

CST905 is a potent BRAF-V600E PROTAC degrader with a DC50 of 18 nM. CST905 recruits the VHL E3 ligase to form a ternary complex, mediating the degradation of BRAF-V600E via the ubiquitin-proteasome pathway. The ligand of CST905 disrupts the RAF dimerization interface, thereby preventing the aberrant activation of the harmful MAPK/ERK pathway in RAS-mutated cells while degrading the target protein. CST905 can be used in studies related to malignant melanoma and neuroblastoma .
loading...
    loading...
Cat. No.: HY-155315
CAS No.: 2998928-27-9
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Tubulin polymerization-IN-51(compound 7u) is a tubulin polymerization inhibitor with IC50 value of 2.55 - 17.89μM for SK-Mel-28 cells. Tubulin polymerization-IN-51 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-155314
CAS No.: 2998928-21-3
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Tubulin polymerization-IN-50 (compound 7n) is a inhibitor of tubulin polymerization, with the IC50 of 5.05 μM in SK-Mel-28 cells. Tubulin polymerization-IN-50 induces the cell cycle arrest in the G2/M phase .
loading...
    loading...
Cat. No.: HY-162045
Research Areas:  

Cancer

Ru-4T is a phototherapy agent. Ru-4T has phototherapeutic efficacy (PI = 114,000) against melanoma cells (SK-MEL-28) under broad-band visible light (400-700 nm) with EC50 values of 740 pM .
loading...
    loading...
Cat. No.: HY-161786
Bcl-2-IN-20 (Compound 81) is an inhibitor for Bcl-2 with IC50 <10 μM (79.1% inhibition at 9 μM). Bcl-2-IN-20 exhibits cytotoxicity in SK-MEL-28 (IC50>10 μM), A549 (IC50=6.1 μM), HepG2 (IC50>10 μM), MCF-7 (IC50=8.9 μM), HCT116 (IC50>10 μM) and HEK-293 (IC50=14.1 μM). Bcl-2-IN-20 promotes the ROS production, induces apoptosis and DNA damage .
loading...
    loading...
Cat. No.: HY-W317408
CAS No.: 5157-89-1
Research Areas:  

Others

(+)-Menthyl acetate is a compound isolated from natural Cunila angustifolia Benth essential oil. The selectivity of (+)-Menthyl acetate is higher than that of MCF-7 cell line, IC50=34.0 μg?mL -1, and lower than that of SK-Mel-28 cell line, IC50=279.9 μg?mL -1, on A549 cell without fatal .
loading...
    loading...
Cat. No.: HY-179271
Target:  

Carbonic Anhydrase HDAC

Research Areas:  

Cancer

CA/HDAC-IN-1 (Compound 11) is a CA and HDAC inhibitor with Ki values of 7.4 nM, 31.0 nM, and 7.3 nM for hCA II, hCA IX, and hCA XII, respectively, and IC50 values of 0.21 μM and 3.60 μM for HDAC3 and HDAC8, respectively. CA/HDAC-IN-1 has anti-cancer activity against colon cancer, breast cancer, and melanoma .
loading...
    loading...
Cat. No.: HY-178336
CAS No.: 3109965-54-7
AC-340 is a potent hybrid VDR agonist/HDAC inhibitor. AC-340 superinduces VDR target genes (e.g., CYP24A1) and inhibits HDAC6 (IC50 = 0.37 μM) with ~10-fold selectivity over HDAC2. AC-340 induces VDR hyperagonism by causing widespread protein hyperacetylation (e.g., tubulin and H3K9/K27), which leads to elevated H3K27 acetylation on VDR target genes. AC-340 can be used for melanoma cancer research .
loading...
    loading...
Cat. No.: HY-W010978
CAS No.: 873779-78-3
Research Areas:  

Cancer

IMesCuCl is a neutral (NHC) copper (I) complex. IMesCuCl exhibits cytotoxic activity against cancer cells. IMesCuCl can be used in the research of breast cancer, lung cancer, melanoma and glioma .
loading...
    loading...